PRLD compared with EWTX: revenue, margins and what each company keeps, and the suppliers and customers both name

PRLDPrelude Therapeutics Inc

Mkt capRevenueRevenue

EWTXEdgewise Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

PRLDPrelude Therapeutics Inc

EWTXEdgewise Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PRLD 3

INCYIncytecustomer

ABCLAbCellera Biologicscustomer

—Pathos AIunlistedcustomer

Shared 0

No shared counterparties.

Only EWTX 2

—Leerinkunlistedsupplier

—Silicon Valley Bank (SVB)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

PRLDPrelude Therapeutics Inc

3.78▼−1.66%· delayed

Mkt cap$306.4MRevenue$6MQ2 FY26

EWTXEdgewise Therapeutics, Inc.

37.69▼−1.10%· post 37.69· delayed

After hoursNov 3 '26delayed

Mkt cap$4.1BRevenue—

Compare

After hoursNov 3 '26delayed

PRLDPrelude Therapeutics Inc

EWTXEdgewise Therapeutics, Inc.

3.78▼−1.66%delayed

Price

37.69▼−1.10%post 37.69delayed

$306.4M

Mkt cap

$4.1B

Q2 FY26$6M

Revenue

—

PRLD3.78▼−1.66%vsEWTX37.69▼−1.10%After hoursNov 3 '26delayed